VISIOMED GROUP EO 001

Research VISIOMED GROUP EO 001 (7V91) on Bullrun: market cap EUR 55.09M, P/E 18.0. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker7V91
• ExchangeF
• CountryFrance
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyEUR
• Market capEUR 55.09M
• P/E18.0
• Financial periodFY2024
• RevenueEUR 17.26M
• Revenue growth25.9%
• Net incomeEUR 1.41M
• Free cash flowEUR 166.00K
• Gross margin47.8%

Valuation Snapshot

latest market cap is EUR 55.09M; P/E is 18.0.

About VISIOMED GROUP EO 001

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union. It operates digitalized medical centers that provide administrative screenings for residency and work visas, preventive health check-ups, and medical fitness tests under the Smart Salem brand. Additionally, the company engages in the production of pharmaceuticals.

Frequently asked questions

What is VISIOMED GROUP EO 001's market cap?

VISIOMED GROUP EO 001's market capitalization is EUR 55.09M.

What is VISIOMED GROUP EO 001's P/E ratio?

VISIOMED GROUP EO 001's price-to-earnings (P/E) ratio is 18.0.

What does VISIOMED GROUP EO 001 do?

Klea Holding SA, together with its subsidiaries, develops health technologies and services in France, the United Arab Emirates, Saudi Arabia, and the European Union.